Answers are grounded in this paper and cite their sources.
In the January Supplement of Diabetes Care , the American Diabetes Association (ADA) has published the newest version of the “Standards of Medical Care in Diabetes” (1). These Standards provide guidelines to help clinicians in the management of their patients with diabetes or at risk for diabetes. Published in one form or another since 1989, the Standards cover multiple aspects of clinical care, such as screening and diagnosis, glycemic management, and cardiovascular risk reduction. Over the past decade, the ADA has made a concerted effort to be transparent and evidence-based in its guideline development as recommended by the Institute of Medicine for guideline-setting organizations (2). We reviewed the ADA recommendations from the past decade to assess trends in the quality of evidence cited to support these recommendations. Each year, the recommendations in the Standards are reviewed and revised in light of emerging and changing evidence. We examined the total number and evidence level for all bulleted recommendations made by the Standards of Care each year from 2005 to 2014. Recommendations are assigned ratings of A, B, C, or E depending on the quality of evidence (Table 1). For our analyses of trends over the past decade, we combined A- and B-level recommendations into a “higher-level evidence” category and combined C- and E-level recommendations into a “lower-level evidence” category. We then calculated the proportion of overall recommendations that were based on higher-level evidence each year. We also examined trends in the recommendations within …
No takes yet. Share an insight, caveat, or question.
Grant et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: